CIRRHOSIS OF THE LIVER Clinical Trials

28 clinical trials for CIRRHOSIS OF THE LIVER across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Oral Branched-chain Amino Acid Supplementation for Cirrhotic Patients With Sarcopenia — RECRUITING · PHASE3
• Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer — RECRUITING
• Optimized Remission in Alcohol-related Liver Cirrhosis — RECRUITING · NA
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY TO EVALUATE THE EFFECT OF SELADELPAR ON CLINICAL OUTCOMES IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) AND COMPENSATED CIRRHOSIS — RECRUITING
• A PHASE III DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL TO EVALUATE LIVER-RELATED CLINICAL OUTCOMES AND SAFETY OF ONCE WEEKLY INJECTED SURVODUTIDE IN PARTICIPANTS WITH COMPENSATED NON-ALCOHOLIC STEATOHEPATITIS/METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (NASH/MASH) CIRRHOSIS — RECRUITING · PHASE3
• EFFECTS OF NNC0194-0499 ALONE AND IN COMBINATION WITH SEMAGLUTIDE, OF SEMAGLUTIDE ALONE, AND OF CAGRILINTIDE ALONE AND IN COMBINATION WITH SEMAGLUTIDE ON LIVER DAMAGE AND ALCOHOL USE IN PEOPLE WITH ALCOHOL-RELATED LIVER DISEASE — RECRUITING
• A PHASE III RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, TWO-ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELAFIBRANOR 80 MG ON LONG-TERM CLINICAL OUTCOMES IN ADULT PARTICIPANTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) — RECRUITING · PHASE3
• A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AXA1665 IN SUBJECTS WITH LIVER CIRRHOSIS AND PRIOR OVERT HEPATIC ENCEPHALOPATHY (EMMPOWER) — RECRUITING · PHASE2
• A SEAMLESS, ADAPTIVE, PHASE 2B/3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, INTERNATIONAL STUDY EVALUATING THE EFFICACY AND SAFETY OF BELAPECTIN (GR-MD-O2) FOR THE PREVENTION OF ESOPHOGEAL VARICES IN NASH CIRRHOSIS — RECRUITING · PHASE2
• A prospective, randomized placebo controlled feasibility trial of faecal microbiota transplantation in cirrhosis. — COMPLETED · PHASE2
• A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, 2-ARM STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF EFIMOSFERMIN ALFA INJECTION IN ADULT PARTICIPANTS WITH COMPENSATED CIRRHOSIS DUE TO METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (NEBULA-1) — NOT_YET_RECRUITING · PHASE3
• Ultrasound Assessment of Diaphragmatic Structure and Function in Patients With Liver Cirrhosis: A Point-of-Care Tool for Predicting Complications and Sarcopenia in Limited Resource Settings — NOT_YET_RECRUITING
• Composition for Treating Cirrhosis and Liver Cancer (SB-1121) — COMPLETED · PHASE4
• MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease — COMPLETED
• A TWO PART PHASE IIA/B MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP DOSE-RANGING STUDY TO ASSESS EFFICACY, SAFETY, AND TOLERABILITY OF THE COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN, AND DAPAGLIFLOZIN MONOTHERAPY VERSUS PLACEBO IN PARTICIPANTS WITH CIRRHOSIS WITH FEATURES OF PORTAL HYPERTENSION — NOT_YET_RECRUITING · PHASE2
• Trial of Faecal Microbiota Transplantation in Cirrhosis — COMPLETED · PHASE3
• Frailty in Patients With Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of Multifactorial Intervention — COMPLETED · NA
• RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND PARALLEL GROUP TRIAL TO INVESTIGATE THE EFFECTS OF ONE DOSE (UP-TITRATION TO A FIXED DOSE REGIMEN) OF ORAL BI 685509 ON PORTAL HYPERTENSION AFTER 8 WEEKS TREATMENT IN PATIENTS WITH CLINICALLY SIGNIFICANT PORTAL HYPERTENSION (CSPH) IN DECOMPENSATED CIRRHOSIS AFTER THEIR FIRST DECOMPENSATION EVENT, WHO ARE STABILIZED CTP 5-7, PHASE II — COMPLETED · PHASE2
• Analysis of the intrahepatic immune landscape in correlation with rising portal hypertension in patients with liver cirrhosis — NOT_YET_RECRUITING
• A MULTI-CENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, ADAPTIVE DOSE RANGING STUDY TO ASSESS SAFETY AND EFFICACY OF INTRAVENOUS OCE-205 IN ADULTS DIAGNOSED WITH CIRRHOSIS WITH ASCITES WHO HAVE DEVELOPED HEPATORENAL SYNDROME ACUTE KIDNEY INJURY (HRS-AKI) — COMPLETED
• RANDOMISED, OPEN-LABEL AND PARALLEL GROUP TRIAL TO INVESTIGATE THE EFFECTS OF ORAL BI 685509 ALONE OR IN COMBINATION WITH EMPAGLIFLOZIN ON PORTAL HYPERTENSION AFTER 8 WEEKS TREATMENT IN PATIENTS WITH CLINICALLY SIGNIFICANT PORTAL HYPERTENSION (CSPH) IN COMPENSATED CIRRHOSIS — NOT_YET_RECRUITING
• PREVENTION OF MORTALITY WITH LONG-TERM ADMINISTRATION OF HUMAN ALBUMIN IN SUBJECTS WITH DECOMPENSATED CIRRHOSIS AND ASCITES — NOT_YET_RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTIPLE-DOSE PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BMS-986263 IN ADULTS WITH COMPENSATED CIRRHOSIS FROM NONALCOHOLIC STEATOHEPATITIS (NASH) — COMPLETED · PHASE2
• The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study) — WITHDRAWN · NA
• Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites — COMPLETED · NA
• A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OBETICHOLIC ACID IN SUBJECTS WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS — COMPLETED · PHASE3
• A SINGLE-BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 18F-FLUORODEOXYGALACTOSE (18F-FDGAL) COMPARED TO 18F-FFLUORODEOXYGLUCOSE (18F-FDG) TO DETECT HEPATOCELLULAR CARCINOMA VIA PET/CT IN PATIENTS WITH CIRRHOSIS OR CHRONIC LIVER DISEASE — NOT_YET_RECRUITING
• HRQoL in the Low MELD Pre-tx Population — COMPLETED

Refine this search